aspirin

Generic: aspirin

Labeler: advance pharmaceutical inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH FINAL Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin
Generic Name aspirin
Labeler advance pharmaceutical inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
Advance Pharmaceutical Inc.

Identifiers & Regulatory

Product NDC 17714-010
Product ID 17714-010_5cc8b5f1-4ae4-471b-e053-2991aa0a84c1
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH FINAL
Application Number part343
Listing Expiration 2026-12-31
Marketing Start 2002-01-09

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 17714010
Hyphenated Format 17714-010

Supplemental Identifiers

RxCUI
212033
UPC
0017714010034 0017714010010
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number part343 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (17714-010-01)
  • 300 TABLET in 1 BOTTLE (17714-010-03)
  • 1000 TABLET in 1 BOTTLE (17714-010-10)
source: ndc

Packages (3)

17714-010-01 100 TABLET in 1 BOTTLE (17714-010-01) 17714-010-03 300 TABLET in 1 BOTTLE (17714-010-03) 17714-010-10 1000 TABLET in 1 BOTTLE (17714-010-10)

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Aspirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "5cc8b5f1-4ae4-471b-e053-2991aa0a84c1", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0017714010034", "0017714010010"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["f2e7332a-bcd6-4aef-9e4c-a2cef5ea9464"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Advance Pharmaceutical Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (17714-010-01)", "package_ndc": "17714-010-01", "marketing_start_date": "20151201"}, {"sample": false, "description": "300 TABLET in 1 BOTTLE (17714-010-03)", "package_ndc": "17714-010-03", "marketing_start_date": "20151201"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (17714-010-10)", "package_ndc": "17714-010-10", "marketing_start_date": "20020109"}], "brand_name": "Aspirin", "product_id": "17714-010_5cc8b5f1-4ae4-471b-e053-2991aa0a84c1", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "17714-010", "generic_name": "Aspirin", "labeler_name": "Advance Pharmaceutical Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "part343", "marketing_category": "OTC MONOGRAPH FINAL", "marketing_start_date": "20020109", "listing_expiration_date": "20261231"}